Loading...
Loading...
Application UK00917866946 · Registered
| Application Number | UK00917866946 |
| Status | Registered |
| Owner | amcure GmbH |
| Filed | 2018-02-28 |
| Registered | 2018-07-06 |
| Renewal Due | 2028-02-28 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. amcure is currently a registered UK trademark, with renewal due on 2028-02-28. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceuticals, namely active ingredients and medicines for angiogenesis, for inhibiting tumour metastasis and for treating other angiogenesis-based pathologies, peptides or peptidomimetics in the form of markers for the diagnostic sector for inhibiting tumour angiogenesis, growth and metastasis, all of the aforesaid goods belonging to the field of oncology.
Medical and pharmacological research services, Namely research and development of new therapeutics and diagnostics in the field of oncology; Scientific and technological services and research, commissioned research and design relating thereto, namely relating to natural science and technology, and consultancy and information in the context of scientific collaborations and information in the technology sector, included in class 42, in the field of oncology.
Medical and veterinary services, namely treatment of patients, arranging and conducting of medical analyses in connection with treating patients, pharmaceutical consultancy in the field of oncology.
'amcure' is a registered trademark on the UK IPO register, owned by amcure GmbH. The application (UK00917866946) was filed on 28 February 2018 and registered on 6 July 2018. The registration is set to expire on 28 February 2028.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Pinsent Masons LLP.
UK trademark UK00917866946 for the mark 'amcure' in Class 5, 42, 44 is recorded on the UK IPO register as owned by amcure GmbH. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00917866946 for the mark 'amcure' as registered.
UK trademark UK00917866946 for the mark 'amcure' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceuticals, namely active ingredients and medicines for angiogenesis, for inhibiting tumour metastasis and for treating other angiogenesis-based pathologies, peptides or peptidomimetics in the form of markers for the diagnostic sector for inhibiting tumour angiogenesis, growth and metastasis, all of th…
UK trademark UK00917866946 for the mark 'amcure' was filed at the UK IPO on 28 February 2018 and registered on 6 July 2018.
UK trademark UK00917866946 for the mark 'amcure' is currently recorded as valid until 28 February 2028, at which point it will need to be renewed with the UK IPO to remain in force.
Pinsent Masons LLP is listed as the attorney / representative of record for UK trademark UK00917866946 for the mark 'amcure' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.